Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

teva gmbh - fingolimodhydrochlorid - kapsler, hårde - 0,5 mg

Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

glenmark pharmaceuticals nordic ab - fingolimodhydrochlorid - kapsler, hårde - 0,5 mg

Union européenne - danois - EMA (European Medicines Agency)

takeda pharma a/s - vedolizumab - colitis, ulcerative; crohn disease - selektive immunosuppressiva - colitis colitisentyvio er indiceret til behandling af voksne patienter med moderat til svær aktiv colitis ulcerosa, der har haft et utilstrækkeligt respons med, tabt svar på, eller var intolerante til enten konventionel behandling eller en tumor nekrose faktor alfa (tnfa) antagonist. crohns diseaseentyvio er indiceret til behandling af voksne patienter med moderat til svær aktiv crohns sygdom, der har haft et utilstrækkeligt respons med, tabt svar på, eller var intolerante til enten konventionel behandling eller en tumor nekrose faktor alfa (tnfa) antagonist. pouchitisentyvio is indicated for the treatment of adult patients with moderately to severely active chronic pouchitis, who have undergone proctocolectomy and ileal pouch anal anastomosis for ulcerative colitis, and have had an inadequate response with or lost response to antibiotic therapy.

Union européenne - danois - EMA (European Medicines Agency)

mylan ireland limited - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Union européenne - danois - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - dimethylfumarat - enterokapsler, hårde - 120 mg

Union européenne - danois - EMA (European Medicines Agency)

teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Union européenne - danois - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

hexal a/s - dimethylfumarat - enterokapsler, hårde - 120 mg

Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

baxter a/s - ifosfamid - pulver til injektions-/infusionsvæske, opløsning - 500 mg